AiCure’s phone app helps clinical trials keep tabs on which participants have taken their medications correctly and which have not.
Frost & Sullivan IDs Five New Technologies to Power Research Across Preclinical Disease Models Published: July 16, 2020 BioSpace When the CEOs of young, innovative biotech companies discuss how their new technologies came to be, they almost inevitably mention a convergence of technologies that was pivotal in transforming an idea into a therapeutic, diagnostic, tool […]
EVERSANA, a leading provider of commercial services to the life science industry, announced the acquisition of HVH Precision Analytics and its predictive analytics platform.
As the J.P. Morgan Healthcare Conference entered the final day for 2020, a few topics rose to the top as trending, including the relative lack of big deals.
Prescription drug errors are a leading source of harm in health care, resulting in substantial morbidity, mortality and health care costs estimated at more than $20 billion annually in the United States.
HVH Precision Analytics announced a proprietary artificial intelligence and machine learning platform used to predict patterns and provide insights to help make informed critical business decisions.
AstraZeneca topped the first annual Pharmaceutical Invention Index, released by IDEA Pharma.
Researchers at the University of Strathclyde in Glasgow, Scotland, potentially developed a blood test for brain cancer using high-throughput attenuated total reflection (ATR)-Fourier transform infrared (FTIR) spectroscopy with machine learning.
AstraZeneca struck a deal to use Schrödinger’s advanced computing platform to help accelerate drug discovery efforts.
LabTwin GmbH, the world’s first voice and AI-powered digital lab assistant, announced the company’s new open API that will connect scientists with data sources both inside and outside of the lab.